Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy

Fig. 6

Histological analysis of the heart. ac Representative images of histological sections stained with Sirius Red: a control group, b Dox + placebo group and c Dox + CM-mESC group after 45 days of cell therapy. d No changes in myocardial collagen fiber content. One-way ANOVA with a Bonferroni post test. Data shown as mean ± standard deviation; n = 5 for each group. Dox doxorubicin, CM-mESC cardiomyocytes derived from mouse embryonic stem cell

Back to article page